Updated:
Watson Fund
Watson Fund is a healthcare venture capital fund that invests in early-stage life science opportunities. It primarily invests in companies developed by...
Overview
Watson Fund is a healthcare venture capital fund that invests in early-stage life science opportunities. It primarily invests in companies developed by Accelerator Corporation, with follow-on investments in companies meeting pre-defined milestones. Watson Fund has made 4 investments, including a Series B investment in Proniras on December 29, 2023.
General information
Firm type
Private Equity
Location
Region
North America
Country
United States
City
Seattle
Corporate office
Seattle, WA, United States
Frequently asked questions
Is Watson Fund structured as a traditional private equity firm or does it operate more like a venture capital fund?
Despite labeling itself as a private equity manager, Watson Fund's stage focus on seed and start-up investments aligns it more closely with venture capital in practice. The firm does not appear to pursue control buyouts, growth equity, or later-stage recapitalizations. Its early-stage concentration places it in a hybrid category common among small Pacific Northwest managers.
Does Watson Fund participate in fund commitments or only direct deals?
Available records suggest Watson Fund invests directly into portfolio companies rather than acting as a fund-of-funds. There is no public evidence of the firm committing capital to third-party GPs or participating in co-investment vehicles alongside larger institutional managers. Its lean structure supports a direct-deal model typical of regionally-focused early-stage investors.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: